RSV每年奪全美1.4萬條人命！美擴大疫苗施打年齡

Reported about 1 year ago

美國FDA批准葛蘭素史克的RSV疫苗適用年齡擴大至50至59歲成年人，以應對每年在美國導致1.4萬人死亡的RSV。該疫苗名為Arexvy，表現良好，並預計未來可擴大至更多年齡層。RSV主要影響肺部和呼吸道，致病症狀嚴重者可能需住院治療。

You may also interested in these wikis

S&P 500 Update: State Street and BlackRock Shares Decline, Nvidia Sees Gains

Three Key Impacts of Trump's Tax Legislation on Your Finances

Tesla, Kenvue, and Synopsys-Ansys Deal: Key Market Updates

Big Banks Earnings: What to Expect This Week

Traders Hasten to Import Brazilian Coffee Ahead of Trump's Tariff

Amogy Secures $80M in Funding to Propel Ammonia-Powered Energy Solutions

BlackRock Achieves Record $12.5 Trillion in Assets Amid Market Volatility

Stock Market Update: Rocket Lab, Fastenal, Best Buy

Rolls-Royce Invests $75 Million to Expand Manufacturing in South Carolina

Dollar rides Treasury yields higher as Trump's tariffs begin to bite

Back to all Wikis